Loading clinical trials...
Loading clinical trials...
Impact of Arterial Oxygen Saturation Range on Ventilatory Stability in Extremely Premature Infants
This is a prospective crossover study to compare the within-subject effect of the two target ranges of arterial oxygen saturation (SpO2), both within the clinically recommended range of 90- 95%. The specific objective of this study to evaluate the impact of targeting SpO2 within 93-95% compared to the 90-92% range on ventilatory stability in premature infants of 23-29 weeks gestational age (GA).
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
Holtz Children's Hospital
Miami, Florida, United States
Start Date
November 1, 2018
Primary Completion Date
November 8, 2019
Completion Date
November 8, 2019
Last Updated
May 10, 2023
19
ACTUAL participants
Targeting SpO2 at 93-95%
OTHER
Targeting SpO2 at 90-92%
OTHER
Lead Sponsor
University of Miami
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06518603